CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Zhejiang Jiuzhou Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Zhejiang Jiuzhou Pharmaceutical Co Ltd
No.99, Waisha Road, Jiaojiang District
Phone: +86 57688706789p:+86 57688706789 TAIZHOU, ZHJ  318000  China Ticker: 603456603456
Business Summary
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based company mainly engaged in the production, sales and service of chemical raw materials and intermediates. The Company is committed to providing one-stop customized pharmaceutical contract development and manufacturing organization (CDMO) services to global pharmaceutical companies, biotechnology companies, scientific research institutions, and others, including small molecule chemical drugs, peptide drugs, conjugated drugs and small nucleic acid drugs. The CDMO projects served by the Company involve therapeutic areas such as anti-tumor, anti-heart failure, anti-depression, treatment of Parkinson's disease, anti-lung cancer, anti-virus, anti-diabetes, and anti-respiratory system infection.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board LirongHua 55 3/28/2023 11/18/2014
President, Director YijiangMei 48 3/28/2023 6/7/2016
Finance Director, Vice President, Director YujieSha 44 12/4/2023 5/18/2021
10 additional Officers and Directors records available in full report.

General Information
Number of Employees: 4,877 (As of 12/31/2023)
Outstanding Shares: 895,235,828 (As of 11/19/2024)
Shareholders: 38,633
Stock Exchange: SHA
Fax Number: +86 57688706788


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024